Chimerism-Based Pre-Emptive Immunotherapy with Fast Withdrawal of Immunosuppression and Donor Lymphocyte Infusions after Allogeneic Stem Cell Transplantation for Pediatric Hematologic Malignancies-Reference-Cited by-同舟云学术

Chimerism-Based Pre-Emptive Immunotherapy with Fast Withdrawal of Immunosuppression and Donor Lymphocyte Infusions after Allogeneic Stem Cell Transplantation for Pediatric Hematologic Malignancies

Published:2015-04 Issue:4 Volume:21 Page:729-737
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Horn Biljana,Petrovic Aleksandra,Wahlstrom Justin,Dvorak Christopher C.,Kong Denice,Hwang Jimmy,Expose-Spencer Jueleah,Gates Michael,Cowan Morton J.

Funder

Thrasher Research Fund

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference31 articles.

1. Transplantation conditioning regimens and outcomes after allogeneic hematopoietic cell transplantation in children and adolescents with acute lymphoblastic leukemia;Tracey;Biol Blood Marrow Transplant,2013

2. Outcomes of allogeneic hematopoietic cell transplantation for adolescent and young adults compared with children and older adults with acute myeloid leukemia;Majhail;Biol Blood Marrow Transplant,2012

3. Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT;Bader;Bone Marrow Transplant,1998

4. Chimerism status is a useful predictor of relapse after allogeneic stem cell transplantation for acute leukemia;Barrios;Haematologica,2003

5. Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective;Bader;Bone Marrow Transplant,2004

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering the best transplant outcome for high-risk acute myeloid leukemia: the donor, the graft and beyond;Cytotherapy;2023-12

2. Donor lymphocyte infusion for prophylaxis and treatment of relapse in pediatric hematologic malignancies after allogeneic hematopoietic stem cell transplant;Journal of the Chinese Medical Association;2023-09-12

3. Is It Possible to Separate the Graft-Versus-Leukemia (GVL) Effect Against B Cell Acute Lymphoblastic Leukemia From Graft-Versus-Host Disease (GVHD) After Hematopoietic Cell Transplant?;Frontiers in Pediatrics;2022-03-24

4. Chimerism analysis for clinicians: a review of the literature and worldwide practices;Bone Marrow Transplantation;2022-01-26

5. Association of early donor chimerism status with survival outcomes in post allogeneic hematopoietic stem cell transplant patients of nonmalignant diseases;Journal of the Pakistan Medical Association;2021-12-21